Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × Breast Neoplasms × Lapatinib × Clear all

Phase

Status

Completed 98 Terminated 29 Unknown 9 Withdrawn 7 Suspended 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 2 Specimen Handling 2 Fluorouracil 2 Cyclophosphamide 2 trastuzumab biosimilar HLX02 1 tivozanib 1 taletrectinib 1 palbociclib 1 eribulin 1 atezolizumab 1 Tomography, Optical Coherence 1 Testosterone Propionate 1 Testosterone 1 Taxes 1 Tablets 1 Receptors, Chimeric Antigen 1 Radiotherapy 1 Paclitaxel 1 PF-05280014 1 Ontruzant 1 Ogivri 1 Neoadjuvant Therapy 1 NVP-BKM120 1 Methotrexate 1 Lisaftoclax 1 Lapatinib 1 Interpersonal Psychotherapy 1 Interleukin-2 1 Injections 1 Escitalopram 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01589861 2017-03-28

PIKHER2

Institut Paoli-Calmettes

Phase 1/2 Suspended

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡